Connie S Tettenborn

Title: The Innovative Contributions of Connie S Tettenborn

Introduction

Connie S Tettenborn is a notable inventor based in Belmont, California. She has made significant contributions to the field of biotechnology, particularly in the development of compounds that modulate cell proliferation, differentiation, and survival. With a total of two patents to her name, Tettenborn's work has the potential to impact various medical treatments.

Latest Patents

Tettenborn's latest patents include "Substituted triazolo-pyrimidine compounds for modulating cell proliferation, differentiation and survival." This invention discloses erythropoietin-mimetic compounds that modulate the survival, function, or differentiation of kidney cells, neurons, erythroid cells, and other erythropoietin-responsive cells. The compounds are particularly useful in preventing and treating diseases such as anemia, organ injury, and central nervous system disorders. Additionally, they serve as adjuncts to cellular treatments, including stem cell therapies.

Career Highlights

Connie S Tettenborn is currently employed at Stategics, Inc., where she continues to innovate and develop new therapeutic compounds. Her work is characterized by a strong focus on improving patient outcomes through advanced medical research.

Collaborations

Tettenborn has collaborated with notable colleagues, including Juha Punnonen and Jeffrey R Spencer, to further her research and development efforts. These collaborations have enhanced the scope and impact of her inventions.

Conclusion

Connie S Tettenborn's contributions to biotechnology through her innovative patents demonstrate her commitment to advancing medical science. Her work holds promise for improving treatments for various diseases and enhancing patient care.